ArticleScientific reports2026
Taguchi optimisation of ZnO and GO-integrated HA nanocomposite with improved antibacterial performance.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antibacterial PET-G/ZnO Composites: A New Approach to Relaxation Splint Materials in the Treatment of Bruxism.Materials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The concern associated with hydroxyapatite (HA) in dental applications is biofilm formation on the surface, causing tooth decay. Combining HA with antibacterial agents has great potential to avert biofilm formation and increase its antibacterial activity. The novelty of this study lies in the systematic optimization of HA/ZnO/GO nanocomposite synthesis using the Taguchi L9 orthogonal array method (3 factors: HA, GO, and ZnO). Unlike previous HA/GO/ZnO studies focused solely on compositional or biological evaluations, this approach identifies the optimal synthesis parameters statistically, attaining enhanced antibacterial performance. The structural arrangement of the nanocomposite was examined using XRD, TEM, and FESEM. Moreover, the successful interfacial interaction between HA, ZnO, and GO were verified in the nanocomposite through FTIR, TEM, and EDX analyses. The highest effective antibacterial activity was observed for the nanocomposite synthesised under experiment 3 (20.08 mg/mL HA, 0.03 mg/mL GO, and 4.88 mg/mL ZnO), in which the HA/ZnO/GO nanocomposite showed a significantly lower bacterial survival rate of 0.61 log₁₀ CFU/mL than that of 0.97 log₁₀ CFU/mL for pure HA. The results demonstrated the effective antibacterial properties of the nanocomposite, suggesting that the HA/ZnO/GO nanocomposite can be used in oral health applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.